BNIP3L and Parkinson disease: The results demonstrated that the expression levels of BNIP3L and CTTN were significantly higher in healthy tissues compared to PD tissues, while the expression levels of VPS13C and MAP1LC3B were markedly elevated in PD tissues relative to healthy tissues.